Cancer Global Summit-CGS 2026

Tumor microenvironment (TME) is an important player in the development, growth, and treatment of cancer. Tumor Microenvironment session is about interpreting the intricate cellular and molecular networks and vasculature surrounding tumor cells and how they drive the behavior of cancers.

The TME comprises immune cells, fibroblasts, vasculature, signaling molecules, and extracellular matrix. These work together with cancer cells to create a microenvironment that can suppress or promote tumor growth. Studies in the area emphasize the role of the microenvironment in drug resistance, immune evasion, and metastasis. It is crucial to understand these interactions to develop more effective treatments.

This session discusses approaches to target the TME, including adjusting immune cell function, normalizing the vasculature, or interfering with supportive signaling pathways. It also highlights the need for combining TME insights with immunotherapy and targeted therapy to enhance patient benefits. New technologies, including single-cell analysis and cutting-edge imaging, are enabling scientists to chart and research the TME in higher resolution, unveiling new therapeutic strategies.

Delegates will learn about the behavior of the tumor microenvironment, its role in the advancement of cancer, and new methods to control it for improved therapy. This session highlights the pivotal position of the TME in the development of effective personalized oncology treatment.